Interpret this echocardiogram showing normal left ventricular systolic function with an ejection fraction of 50‑55 %, normal left ventricular cavity size, mild asymmetric left ventricular hypertrophy, normal global wall motion, indeterminate diastolic filling pattern, moderately dilated left atrium (42.2 ml/m²), intact interatrial septum on two‑dimensional and color‑flow Doppler imaging, normal right ventricular size and function, mild tricuspid regurgitation, and right ventricular systolic pressure of 26 mmHg.

Echocardiogram Interpretation: Likely Diastolic Dysfunction with Left Atrial Remodeling

This echocardiogram demonstrates findings consistent with diastolic dysfunction, evidenced by the combination of mild asymmetric left ventricular hypertrophy, moderately dilated left atrium (42.2 ml/m²), and indeterminate diastolic filling pattern—a constellation that strongly suggests chronic elevation of left atrial pressure despite preserved systolic function.

Key Findings Analysis

Left Ventricular Structure and Function

• Systolic function is preserved with EF 50-55% and normal global wall motion
• Mild asymmetric LV hypertrophy is present, which according to ACC/AHA definitions indicates wall thickness in one region is disproportionately increased compared with other regions 1
• The asymmetric pattern of hypertrophy is clinically significant—it represents pathologic remodeling that increases LV stiffness and is associated with diastolic dysfunction 2

Critical Finding: Left Atrial Enlargement

The moderately dilated left atrium at 42.2 ml/m² is the most concerning finding on this study. According to ASE/EACVI guidelines, LA maximum volume index >34 ml/m² is abnormal and serves as a marker of chronic elevation of left atrial pressure 2. This degree of LA dilation (42.2 ml/m²) indicates:

• Long-standing diastolic dysfunction
• Chronically elevated filling pressures
• Increased risk for atrial fibrillation
• Higher cardiovascular morbidity and mortality risk

Diastolic Function Assessment

The "indeterminate diastolic filling pattern" in the context of LV hypertrophy and LA dilation is problematic. Per 2016 ASE/EACVI guidelines, proper diastolic function assessment requires evaluation of four key variables 2:

• Annular e′ velocity (septal e′ <7 cm/sec, lateral e′ <10 cm/sec indicates abnormality)
• Average E/e′ ratio (>14 indicates elevated filling pressure)
• LA maximum volume index (>34 ml/m² indicates abnormality)
• TR velocity (>2.8 m/sec indicates elevated pressure)

In this case, you already have one definitive abnormality (LA volume index >34 ml/m²) plus LV hypertrophy, which together strongly suggest diastolic dysfunction even without complete Doppler data.

Right Heart Assessment

• Normal RV size and function
• RVSP 26 mmHg is normal (normal <35 mmHg)
• Mild tricuspid regurgitation is physiologic and common
• No evidence of pulmonary hypertension, which is reassuring

Clinical Implications

What This Means for the Patient

This pattern represents early-stage heart failure with preserved ejection fraction (HFpEF) physiology or a pre-HFpEF state. Research demonstrates that asymmetric LV hypertrophy with LA dilation results from abnormalities of LV relaxation and/or compliance 3. Recent data shows that LV function markers decline progressively with increasing LVH severity, even when EF remains preserved 4.

Recommended Actions

1. Investigate the underlying cause of LV hypertrophy:

   • Hypertension (most common)
   • Hypertrophic cardiomyopathy
   • Infiltrative disease (though symmetric hypertrophy is more typical)
   • Aortic stenosis (check for valvular disease)

2. Obtain complete diastolic assessment if not already done:

   • Tissue Doppler imaging for e′ velocities
   • Mitral inflow E/A ratio
   • E/e′ ratio calculation
   • Consider stress echocardiography if symptoms present with exertion

3. Assess for symptoms of heart failure:

   • Dyspnea on exertion
   • Exercise intolerance
   • Orthopnea or paroxysmal nocturnal dyspnea
   • Peripheral edema

4. Risk stratification for atrial fibrillation given significant LA dilation

5. Optimize cardiovascular risk factors:

   • Blood pressure control is paramount
   • Consider neurohormonal blockade (ACE inhibitors/ARBs, beta-blockers) if hypertensive
   • Manage comorbidities aggressively

Common Pitfalls to Avoid

• Do not dismiss this as "normal" because EF is preserved. The LA dilation and LV hypertrophy indicate underlying pathology that requires investigation and management 2, 5
• Do not assume asymmetric hypertrophy is always benign. While it may represent hypertensive heart disease, hypertrophic cardiomyopathy must be excluded, particularly if septal thickness exceeds 13-15 mm 6
• Do not ignore the indeterminate diastolic pattern. This requires complete Doppler assessment to properly grade diastolic dysfunction and estimate filling pressures 5

Prognosis Considerations

The severity of LV hypertrophy and degree of LA dilation correlate with prognosis 4. The moderately dilated LA suggests this is not early disease, and the patient requires close monitoring and aggressive risk factor modification to prevent progression to symptomatic heart failure.